Healthy Skin is Important to You

Links:

Recent Posts

Tags


 

July 2008
M T W T F S S
« Jun   Aug »
 123456
78910111213
14151617181920
21222324252627
28293031  

Categories +/-

Archive +/-

Links +/-

Meta +/-




Archive for July 9th, 2008

MISSION Product™ Brings High-Performance Skincare To Beijing

MISSION Product™, the first Athlete-Engineered Skincare™ line, congratulates five of its athletes as they prepare to represent the United States in Beijing this summer. Only three months after joining forces to help launch MISSION Product, a line of high-performance skincare products specifically designed by athletes to meet athletic needs, U.S.

This post is an original post by ScienceDaily: Skin Care News

Xclair(R) Reported To Be Safe And Effective In Study Published In European Journal Of Dermatology

ALIGN Pharmaceuticals, LLC, a wholly owned subsidiary of Cyclacel Pharmaceuticals, Inc., (NASDAQ: CYCC, CYCCP) announced results of a double-blinded, randomized, vehicle-controlled clinical study showing that Xclair® cream (formerly MAS065D) is safe and effective in the treatment and prevention of radiation dermatitis. These results were published in the May-June 2008 issue of the European Journal of Dermatology.

This post is an original post by ScienceDaily: Skin Care News

European Commission Announces Marketing Authorisation For 50mg Once Weekly Enbrel(R) For Patients With Moderate-To-Severe Psoriasis

The European Commission announced a new 50mg Enbrel® (etanercept) once weekly dosage regimen as an alternative to the currently approved 25mg Enbrel® twice weekly regimen for the treatment of patients with moderate-to-severe plaque psoriasis. Based on the outcome of the extensive European 318 study in adult patients with moderate-to-severe plaque psoriasis, the European Commission issued the marketing authorisation for the European Union for a once weekly 50mg Enbrel® dosing.

This post is an original post by ScienceDaily: Skin Care News

Ultraviolet Light Therapy Is As Beneficial For Darker Skin As Lighter Skin

An analysis of more than 100 patients has confirmed for the first time that darker-skinned patients benefit as those with lighter skin when given light therapy for morphea and related diseases, UT Southwestern Medical Center researchers show. Phototherapy is the use of ultraviolet light to treat skin disorders, ranging from common problems such as acne and psoriasis to rarer conditions such as scleroderma and morphea, a hardening of the skin.

This post is an original post by ScienceDaily: Skin Care News